| 26th Jul 2018 12:02 pm |
RNS |
Holding(s) in Company |
| 19th Jul 2018 10:19 am |
RNS |
Results of Placing and Subscription |
| 19th Jul 2018 7:00 am |
RNS |
Proposed placing & subscription to raise £10.6m |
| 16th Jul 2018 8:53 am |
RNS |
BLOCK LISTING SIX MONTHLY RETURN |
| 13th Jul 2018 9:40 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Steady performance in a tough market |
| 12th Jul 2018 7:00 am |
RNS |
Trading Update |
| 25th Jun 2018 7:52 am |
RNS |
Positive data of Pollinex Quattro Grass vaccine |
| 29th May 2018 7:00 am |
RNS |
Positive data with house-dust mite immunotherapy |
| 21st May 2018 12:25 pm |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Opening the door to registration |
| 21st May 2018 7:00 am |
RNS |
Positive top-line results from Grass Ph II study |
| 14th May 2018 7:00 am |
RNS |
Publication of MCT Adjuvant Data |
| 16th Mar 2018 3:38 pm |
RNS |
Grant of Awards under Long Term Incentive Plan |
| 16th Mar 2018 12:53 pm |
RNS |
Director/PDMR Shareholding |
| 7th Mar 2018 9:30 am |
RNS |
Hardman: Clinical development towards submission |
| 7th Mar 2018 7:00 am |
RNS |
Interim Results |
| 28th Feb 2018 7:00 am |
RNS |
Polyvac® Peanut CMO appointed |
| 12th Feb 2018 7:00 am |
RNS |
Completion of recruitment in PQ Grass Ph II trial |
| 2nd Feb 2018 7:15 am |
RNS |
Hardman Research: Growth in a tough market |
| 31st Jan 2018 7:00 am |
RNS |
Trading Update |
| 10th Jan 2018 3:19 pm |
RNS |
Holdings in Company |
| 9th Jan 2018 7:00 am |
RNS |
PQ Birch Phase III trial completes recruitment |
| 12th Dec 2017 7:00 am |
RNS |
Co-development agreement with Ergomed plc |
| 7th Dec 2017 5:08 pm |
RNS |
Holding(s) in Company |
| 22nd Nov 2017 11:36 am |
RNS |
Result of AGM |
| 21st Nov 2017 7:00 am |
RNS |
Block Listing Application |
| 13th Nov 2017 7:00 am |
RNS |
Allergy Therapeutics to Present at Jefferies 2017 |
| 7th Nov 2017 12:59 pm |
RNS |
Director/PDMR Shareholding |
| 7th Nov 2017 11:54 am |
RNS |
Director/PDMR Shareholding |
| 19th Oct 2017 4:14 pm |
RNS |
Publication of Annual Report and notice of AGM |
| 19th Oct 2017 7:00 am |
RNS |
Commencement of dosing in PQ Grass Phase II Trial |
| 12th Oct 2017 5:39 pm |
RNS |
Holding(s) in Company |
| 12th Oct 2017 2:55 pm |
RNS |
Director/PDMR Shareholding |
| 10th Oct 2017 7:15 am |
RNS |
Hardman Research: Continuing to gain market share |
| 28th Sep 2017 7:00 am |
RNS |
Preliminary Results |
| 18th Sep 2017 7:00 am |
RNS |
Approval for PQ Grass Phase II trial |
| 11th Sep 2017 7:00 am |
RNS |
Expansion of Clinical Development and R&D teams |
| 15th Aug 2017 7:00 am |
RNS |
Notice of Results |
| 18th Jul 2017 7:00 am |
RNS |
Trading Update |
| 6th Jul 2017 7:00 am |
RNS |
Publication of adjuvant studies in journals |
| 27th Jun 2017 7:00 am |
RNS |
Investor and analyst site visits |
